Table 4 Comparison of clinical characteristics of patients with different pathological types [n (%)]
Influencing factor | FCD group (n = 17) | Non-FCD group (n = 9) | P-value |
|---|---|---|---|
Sex | 0.189 | ||
Male | 12 (70.6) | 4 (44.4) | |
Female | 5 (29.4) | 5 (55.6) | |
Age at seizure onset | 0.365 | ||
< 6 months | 12 (70.6) | 5 (55.6) | |
6 months–1 year | 5 (29.4) | 4 (44.4) | |
Age at surgery | 0.079 | ||
< 1 year | 5 (29.4) | 6 (66.7) | |
> 1 year | 12 (70.6) | 3 (33.3) | |
Seizure duration | 0.048 | ||
Within 1 year | 6 (35.3) | 7 (77.8) | |
Over 1 year | 11 (64.7) | 2 (22.2) | |
Seizure type | 0.413 | ||
Epileptic spasm | 6 (35.3) | 2 (22.2) | |
Combined with other types of seizure | 11 (64.7) | 7 (77.8) | |
MRI | 0.159 | ||
Positive | 13 (76.5) | 9 (100.0) | |
Negative | 4 (23.5) | 0 (0.0) | |
PET-MRI | 0.159 | ||
Positive | 13 (76.5) | 9 (100.0) | |
Negative | 4 (23.5) | 0 (0.0) | |
Surgery type | 0.500 | ||
Hemispherectomy | 9 (52.9) | 4 (44.4) | |
Non-hemispherectomy | 8 (47.1) | 5 (55.6) | |
Outcome | 0.420 | ||
Engel (I–II) | 13 (76.5) | 8 (88.9) | |
Engel (III–IV) | 4 (23.5) | 1 (11.1) |